TheJobsMapParthenon Therapeutics jobs and careers
Cambridge, MA, United States
About Parthenon Therapeutics
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on rigorous, groundbreaking research, we are designing a portfolio of drug candidates to treat the right patients at the right time.
Founded in 2019 by Guy Clifton, Laurent Audoly and Olga Granaturova.
- Founded
- 2019
- Employees
- 11 to 50
- Total funding
- $65M
- Headquarters
- Cambridge
Leadership
The top of Parthenon Therapeutics's org chart, with how many people report into each leader.
Laurent Audoly
CEO & Co-Founder
24 reports
Thomas Schürpf
Vice President, Head of Development
18 reports
Irena Lerentracht Webster
Svp, Development And Operations
1 report
Joseph Paul Eder
Chief Medical Officer
C. Glenn Begley
Co-Founder, Head of Target Discovery
John Goldberg
Acting Chief Development Officer
Board
Melissa Lambeth Kemp
Scientific Advisor
Marina Kochetkova
Scientific Advisor
Rong Li
Scientific Advisor
Ezogelin Oflazoglu-Gruyters
Scientific Advisor
Paolo Provenzano
Scientific Advisor
Michael Cecchini
Scientific Advisor
Jobs at Parthenon Therapeutics
No open positions right now. Explore more companies on TheJobsMap.